L
Luca Schifanella
Researcher at National Institutes of Health
Publications - 20
Citations - 687
Luca Schifanella is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Medicine & Cytotoxic T cell. The author has an hindex of 10, co-authored 15 publications receiving 560 citations. Previous affiliations of Luca Schifanella include University of Milan.
Papers
More filters
Journal ArticleDOI
Adjuvant-dependent Innate and Adaptive Immune Signatures of Risk of SIVmac251 Acquisition
Monica Vaccari,Shari N. Gordon,Slim Fourati,Luca Schifanella,Luca Schifanella,Namal P.M. Liyanage,Mark J. Cameron,Brandon F. Keele,Xiaoying Shen,Georgia D. Tomaras,Erik Billings,Mangala Rao,Amy W. Chung,Karen G Dowell,Chris Bailey-Kellogg,Eric P. Brown,Margaret E. Ackerman,Diego A. Vargas-Inchaustegui,Stephen Whitney,Melvin N. Doster,Nicolo Binello,Poonam Pegu,David C. Montefiori,Kathryn E. Foulds,David S Quinn,Mitzi M. Donaldson,Frank Liang,Karin Loré,Mario Roederer,Richard A. Koup,Adrian B. McDermott,Zhong-Min Ma,Christopher J. Miller,Tran B. Phan,Donald N. Forthal,Matthew Blackburn,Francesca Caccuri,Massimiliano Bissa,Guido Ferrari,Vaniambadi S. Kalyanaraman,Maria Grazia Ferrari,DeVon Thompson,Marjorie Robert-Guroff,Silvia Ratto-Kim,Jerome H. Kim,Nelson L. Michael,Sanjay Phogat,Susan W. Barnett,Jim Tartaglia,David Venzon,Donald Stablein,Galit Alter,Rafick-Pierre Sekaly,Genoveffa Franchini +53 more
TL;DR: It is found here that an ALVAC–simian immunodeficiency virus (SIV) and gp120 alum (ALVAC-SIV + gp120) equivalent vaccine, but not an ALvAC–SIV - gp120 MF59 vaccine, was efficacious in delaying the onset of SIVmac251 in rhesus macaques, despite the higher immunogenicity of the latter adjuvant.
Journal Article
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition (vol 22, pg 762, 2016)
Monica Vaccari,Shari N. Gordon,Slim Fourati,Luca Schifanella,Namal P.M. Liyanage,Mark J. Cameron,Brandon F. Keele,Xiaoying Shen,Georgia D. Tomaras,Erik Billings,Mangala Rao,Amy W. Chung,Karen G Dowell,Chris Bailey-Kellogg,Eric P. Brown,Margaret E. Ackerman,Diego A Vargas-Inchaustegui,Stephen Whitney,Melvin N. Doster,Nicolo Binello,Poonam Pegu,David C. Montefiori,Kathryn E. Foulds,David S Quinn,Mitzi M. Donaldson,Frank Liang,Karin Loré,Mario Roederer,Richard A. Koup,Adrian B. McDermott,Zhong-Min Ma,Christopher J. Miller,Tran B. Phan,Donald N. Forthal,Matthew Blackburn,Francesca Caccuri,Massimiliano Bissa,Guido Ferrari,Vaniambadi S. Kalyanaraman,Maria Grazia Ferrari,DeVon Thompson,Marjorie Robert-Guroff,Silvia Ratto-Kim,Jerome H. Kim,Nelson L. Michael,Sanjay Phogat,Susan W. Barnett,Jim Tartaglia,David Venzon,Donald M Stablein,Galit Alter,Rafick-Pierre Sekaly,Genoveffa Franchini +52 more
Journal ArticleDOI
Leishmaniasis: new insights from an old and neglected disease
TL;DR: Improvement in diagnostic methods has been obtained through the implementation of molecular amplification methods and using the rK39 antigen as the substrate, as well as the use of various antileishmanial drugs in combination.
Journal ArticleDOI
HIV vaccine candidate activation of hypoxia and the inflammasome in CD14 + monocytes is associated with a decreased risk of SIV mac251 acquisition
Monica Vaccari,Slim Fourati,Shari N. Gordon,Dallas R. Brown,Massimiliano Bissa,Luca Schifanella,Isabela Silva de Castro,Melvin N. Doster,Veronica Galli,Maria Omsland,Dai Fujikawa,Giacomo Gorini,Namal P.M. Liyanage,Hung V. Trinh,Hung V. Trinh,Katherine McKinnon,Kathryn E. Foulds,Brandon F. Keele,Mario Roederer,Richard A. Koup,Xiaoying Shen,Georgia D. Tomaras,Marcus P. Wong,Karissa J Muñoz,Johannes S. Gach,Donald N. Forthal,David C. Montefiori,David Venzon,Barbara K. Felber,Margherita Rosati,George N. Pavlakis,Mangala Rao,Rafick Pierre Sekaly,Genoveffa Franchini +33 more
TL;DR: The data indicate that the selective engagement of monocyte subsets following a vaccine prime influences long-term immunity, uncovering an unexpected association of CD14+ innate monocytes with a reduced risk of SIVmac251 acquisition.
Journal ArticleDOI
Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years.
Spinello Antinori,Luca Schifanella,Matthieu Million,Laura Galimberti,Laurenzia Ferraris,Luca Mandia,Giuseppe Trabucchi,Viviana Cacioppo,Gaspare Monaco,Antonella Tosoni,Philippe Brouqui,Maria Rita Gismondo,G. Giuliani,Mario Corbellino +13 more
TL;DR: Western physicians should be aware of the typical (eye worm migration and Calabar swellings) as well as unusual clinical presentations of loiasis, due to increasing travel and the migration of people from the endemic countries of West Africa to Europe and the USA.